Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion XL in Female Orgasmic Disorder
NCT00248209Phase 3Completed
- Start
- May 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in female orgasmic disorder (FOD). Started May 2004; status: completed.
02
Drugs
bupropion
03
Conditions
female orgasmic disorder (FOD)
Beyond the preview
Go deeper on NCT00248209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248209.